Wednesday, Feb 26, 10:00 AM – 11:00 AM PST
Details
Join us for our CSPN Clinical Spotlight Session on the clinical use of hypnosis in cancer supportive care.
Hypnosis has been increasingly recognized as a valuable complementary therapy in cancer supportive care. Research has shown that it can help address several psychological and physical challenges faced by cancer patients, including pain, anxiety, and nausea, thereby improving their overall quality of life.
- Pain Management: Hypnosis has been found effective in reducing pain perception and the need for pain medication in cancer patients. It helps patients achieve a state of deep relaxation, which can alter their perception of pain and enhance their ability to cope with it.
- Anxiety Reduction: Cancer diagnosis and treatment often lead to significant anxiety and stress. Hypnotherapy can help reduce these feelings by promoting relaxation and providing patients with coping strategies to manage their anxiety.
- Control of Nausea and Vomiting: Hypnosis has also been shown to be effective in controlling nausea and vomiting, which are common side effects of chemotherapy. By using guided imagery and relaxation techniques, hypnotherapy can help patients manage these symptoms more effectively.
- Enhancement of Quality of Life: Overall, hypnosis can contribute to an improved quality of life for cancer patients by addressing both physical symptoms and emotional well-being. It supports holistic healing processes and can be integrated into conventional cancer care to provide a more comprehensive treatment approach.
Meet Our Speaker
Dr. David Spiegel is Willson Professor and Associate Chair of Psychiatry & Behavioral Sciences, and Director of the Center on Stress and Health and the Center for Integrative Medicine at Stanford University School of Medicine. He has published thirteen books, 425 scientific journal articles, and 175 book chapters on hypnosis, psychosocial oncology, stress physiology, trauma, and psychotherapy for stress, PTSD, anxiety, and depression. His research has been supported by the National Institute of Mental Health, the National Cancer Institute, the National Institute on Aging, the National Center for Complementary and Integrative Health, and a number of foundations. He is Past President of the American College of Psychiatrists and the Society for Clinical and Experimental Hypnosis, and is a Member of the National Academy of Medicine. He spoke on hypnosis at the World Economic Forum in Davos in January, 2018. He isCo-Founder and Chief Scientific Officer of Reveri Health, the digital interactive hypnosis app downloadable from the App Store and Google Play.